Sharon Chen
CEOFormer Director of Google Shanghai R&D Institute; Former General Manager of Verily China
AlphaLife Sciences is at the forefront of integrating life sciences with cutting-edge computer science through AuroraPrime, our leading GenAI-powered SaaS platform for clinical research. Backed by Microsoft for Startups (Pegasus Program), Google for Startups, Johnson & Johnson Innovation - JLABS, and the Nvidia Inception Program, we harness advanced GenAI, cloud computing, and data platform to transform clinical trials, automate workflows, and accelerate pharmaceutical development, delivering unmatched efficiency and strategic advantages for pharmaceutical companies.
For clinical research and post-market real-world research, AlphaLife Science Group focuses on building a SaaS platform serving life sciences and consumer health fields with the world's leading computer technology, and realizing process automation and intelligent decision-making driven by clinical research docs and data.
Former Director of Google Shanghai R&D Institute; Former General Manager of Verily China
Former Head of Project Management and Clinical Operation at WuXi Clinical; Former PD of Project Management at Covance (Fortrea)
Former Co-Founder of Saama; Former executive team member at ThoughtSphere
The first engineer at Google China; Former Architect at Verily China
Former Cloud AI Tech Lead at Google Shanghai; Former Clinical Software Tech Lead at Verily China
Former Head of Channel Sales Asia Pacific of Medidata; Former Key Account Solution Sales at Microsoft
Chief Strategy Officer of RemeGen; FormerDeputy Director of FDA’s Division of Gastrointestinal and Coagulation Drug Products, Former MD Chief Scientist of CDE
Board member of CDISC; Former SVP, Head of Biometrics & Information Sciences at AstraZeneca
CEO and Chief Statistician of R&G; Former Associate Division Director of the Division of Biometrics V at CDER, FDA
In 2020, a group of senior technology and product experts from Google and Verily China decided to start a business and delve into the intelligent digitalization of life science clinical research. With the goal of building a SaaS platform for life science and consumer health fields through world-leading computer technology, AlphaLife Sciences was officially established in August 2020. With the vision of "Use technology to advance innovation in life science and consumer health. Faster, more accessible and evidence-based," the AlphaLife team quickly grew and attracted many technology talents from leading global IT companies and senior industry experts from the life sciences field. With the gradual launch of AlphaLife's innovative products, more and more leading life science innovation and development companies, as well as ecosystem partners, choose AlphaLife, collaborate in multiple ways, and jointly explore the future of intelligent digitalization in clinical research.
With experienced staff and trusted partners worldwide, we provide comprehensive support to ensure you have the resources you need, wherever you are.
B Capital Group
Lightspeed China Partners
Hankang Capital